Harms, M., Habib, M. M. W., Nemska, S., Nicolò, A., Gilg, A., Preising, N., Sokkar, P., Carmignani, S., Raasholm, M., Weidinger,
G., Kizilsavas, G., Wagner, M., Ständker, L., Abadi, A. H., Jumaa, H., Kirchhoff, F., Frossard, N., Sanchez-Garcia, E., &
Münch, J. (2021). An optimized derivative of an endogenous CXCR4 antagonist prevents
atopic dermatitis and airway inflammation. Acta Pharmaceutica Sinica B, 11(9),
2694-2708. doi:10.1016/j.apsb.2020.12.005.